Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 15Neoplasms 8cyclopia sequence 7Prostatic Neoplasms 7Polycystic Ovary Syndrome 5Fatigue 5Lung Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Pain 3Obesity 3Neoplasm Metastasis 3Multiple Myeloma 3Leiomyoma 3Vomiting 2Urinary Bladder Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Neoplasms, Plasma Cell 2Nausea 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Insulin Resistance 2Infertility 2Hyperandrogenism 2Hematologic Diseases 2Depression 2Burkitt Lymphoma 2Weight Loss 1

Interventions

Fentanyl 2Sugars 1Fenofibrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Burns × Sugars × Clear all
NCT01574131 2019-11-29

Acute and Long-Term Outcome Investigations of Fenofibrate on Severely Burned Patients

The University of Texas Medical Branch, Galveston

Phase 4 Terminated
3 enrolled

Burns, Insulin Resistance, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡